# CONMED CORP (CNMD)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CNMD/

- Reporting holders: 11
- Reported value: $2.1M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CONFLUENCE INVESTMENT MANAGEMENT LLC](https://holderbook.com/funds/1442056-confluence-investment-management-llc/) | $871.5K | 18,851 | 0.0% | 10 |
| [EPIQ PARTNERS, LLC](https://holderbook.com/funds/1799435-epiq-partners-llc/) | $696.2K | 15,059 | 0.3% | 21 |
| [Fenimore Asset Management Inc](https://holderbook.com/funds/884566-fenimore-asset-management-inc/) | $411.5K | 8,902 | 0.0% | 32 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $44.2K | 956 | 0.0% | 26 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $42.1K | 911 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $21.4K | 463 | 0.0% | 12 |
| [Investors Research Corp](https://holderbook.com/funds/1730630-investors-research-corp/) | $19.2K | 415 | 0.0% | 4 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $1.5K | 33 | 0.0% | 9 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $231 | 5 | 0.0% | 15 |
| [Davis Capital Management](https://holderbook.com/funds/1811806-davis-capital-management/) | $92 | 2 | 0.0% | 2 |
| [GILPIN WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/2058144-gilpin-wealth-management-llc/) | $47 | 1 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 11 | $2.1M |
| Q2 2026 | 251 | $1.2B |
| Q1 2026 | 237 | $1.2B |
| Q4 2025 | 265 | $1.4B |
| Q3 2025 | 271 | $1.6B |
| Q2 2025 | 279 | $1.8B |
| Q1 2025 | 281 | $2.2B |
| Q4 2024 | 279 | $2.5B |
| Q3 2024 | 290 | $2.5B |
| Q2 2024 | 294 | $2.5B |
| Q1 2024 | 302 | $3.0B |
| Q4 2023 | 308 | $4.2B |